128
Participants
Start Date
December 31, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
March 31, 2019
ALD403 (Eptinezumab)
Research Site, Brooklyn
Research Site, Rochester
Research Site, Mt. Pleasant
Research Site, DeLand
Massachusetts, Miami
Research Site, Tampa
Research Site, Winter Haven
Research Site, Bradenton
Research Site, Chattanooga
Research Site, Dayton
Research Site, Minneapolis
Research Site, Prairie Village
Research Site, Fort Worth
Research Site, Colorado Springs
Research Site, Santa Monica
Research Site, San Diego
Research Site, Bellevue
Massachusetts, Boston
Research Site, North Attleboro
02481, Wellesley
Lead Sponsor
Alder Biopharmaceuticals, Inc.
INDUSTRY